tradingkey.logo

Global Medical REIT Inc reports results for the quarter ended December 31 - Earnings Summary

ReutersFeb 27, 2025 11:28 PM
  • Global Medical REIT Inc GMRE.N reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of four analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -1 cents to 1 cents per share.

  • Revenue rose 6.7% to $35.16 million from a year ago; analysts expected $34.63 million.

  • Global Medical REIT Inc's reported EPS for the quarter was 2 cents​.

  • The company reported quarterly net income of $1.37 million.

  • Global Medical REIT Inc shares had risen by 10.0% this quarter.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 1.2% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

  • The average consensus recommendation for the specialized reits peer group is also "buy"

Wall Street's median 12-month price target for Global Medical REIT Inc is $10.00

This summary was machine generated from LSEG data February 27 at 11:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

0.20

0.15

Missed

Sep. 30 2024

0.20

0.19

Missed

Jun. 30 2024

0.20

0.20

Met

Mar. 31 2024

0.21

0.21

Met

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI